PRA Health Sciences’ Early Development Services (EDS) team of dedicated experts understands that obtaining patient safety and efficacy data early in the clinical pharmacology program plays a critical role in decision-making and lays the groundwork for efficient future development planning.
Phase I healthy volunteer studies play a vital role in clinical research by providing researchers with the knowledge they need to make educated…
Human Abuse Potential and Liability (HAP)
We’ve successfully completed more Human Abuse Potential and Liability (HAP/HAL) protocols & published more HAP studies than any other CRO.
Renal Impairment Studies — Early Patient Solutions
PRA Health Sciences’ Early Development Services (EDS) has established a team dedicated to early phase patient studies. Our Early Patient Solutions…